Page last updated: 2024-10-31

mitoxantrone and Adrenal Cortex Cancer

mitoxantrone has been researched along with Adrenal Cortex Cancer in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rashed, WM1
Zekri, W1
Awad, M1
Taha, H1
Abdalla, B1
Alfaar, AS1
Mantzios, G1
Tsirigotis, P1
Veliou, F1
Boutsikakis, I1
Petraki, L1
Kolovos, J1
Papageorgiou, S1
Robos, Y1

Reviews

1 review available for mitoxantrone and Adrenal Cortex Cancer

ArticleYear
Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Addison Disease; Adrenal Cortex Neoplasms; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe

2004

Other Studies

1 other study available for mitoxantrone and Adrenal Cortex Cancer

ArticleYear
Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:2

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma;

2017